Viemed Healthcare Inc VMD

Vent Patients

[donmayne]

VMD's core business is with vent patients.  Up to June 2019, their average growth was 8.8%.  Since then, their average growth was 1.6%.  Their incentive compensation awards are unjustified in the face of the recent under-performance.  The only consolation for the retail investor is that management stock holdings were also negatively affected so they cannot walk away now.  
 

Quarter end	Vent Patients	Quarterly change	% change
2021-09-30	8,200	97	1.2%
2021-06-30	8,103	370	4.8%
2021-03-31	7,733	-159	-2.0%
2020-12-31	7,892	104	1.3%
2020-09-30	7,788	83	1.1%
2020-06-30	7,705	-260	-3.3%
2020-03-31	7,965	206	2.7%
2019-12-31	7,759	338	4.6%
2019-09-30	7,421	291	4.1%
2019-06-30	7130	737	11.5%
2019-03-31	6,393	488	8.3%
2018-12-31	5,905	461	8.5%
2018-09-30	5,444	366	7.2%
2018-06-30	5,078	393	8.4%
2018-03-31	4,685

2021-Q4 was a period post-Delta. Omicron took hold in mid-December when it would have affected patient uploads. The results in Q4 should provide a glimpse of growth in vent patients post pandemic.  Guidance from the company for 2022-Q1 will be quite accurate because they will know the first two months.  But it will be conservative growth and not meaningful because it will reflect an Omicron impact for the first six weeks of 2022. It is because of Omicron that Investors will be looking for revenue and profit guidance farther down the road than Q1 2022.

[Joe455]

Thanks for the good info.

[lscfa]

Viemed is also growing oxygen patients because they eventually become vent patients. 

[donmayne]

Yes indeed. They have several strategies in play to help grow their vent patients.  I am hoping these strategies start to work to allow Viemed to meaningfully grow as it emerges from the pandemic.

[HobbyDigger2]

@don, check your Inbox.